For the Inventor, By the Inventor

Enter assignee name

Augusta, GA, United States of America

Medical College of Georgia Research Institute, Inc.

USPTO Granted Patents = 49

EPO Patents = 1

Forward Citations = 680

Loading Chart...

Loading Chart...

70 inventors (with patents filed for the assignee):

David Munn (8 out of 12 patents)

Andrew L Mellor (8 out of 12 patents)

Nathan E Yanasak (4 out of 5 patents)

4. Tom C Hu (3 out of 3 patents)

5. Jeffrey Roberts Lee (3 out of 4 patents)

6. Fred Rueggeberg (3 out of 3 patents)

7. Lin Mei (2 out of 6 patents)

8. Nirbhai Singh (2 out of 3 patents)

9. Shivan Amin (2 out of 2 patents)

10. Jin-Xiong She (2 out of 4 patents)

11. George S Schuster (2 out of 2 patents)

12. J Warren Beach (2 out of 5 patents)

13. Cong-Yi Wang (2 out of 3 patents)

14. James R Goldenring (2 out of 4 patents)

15. Jerry J Buccafusco (2 out of 4 patents)

Core Competencies:

VEGF Disruption

Surgical Apparatus

Netrin-1 Compositions

ErbB2 Modulation

Nitric Oxide Synthase Antagonists

GPR109 Ligand

T Cell Immunity Regulation

Neural Stem Cell Enrichment

Cognitive Enhancement

Fluoride-Releasing Amalgam

Dopamine Receptor Modulation

Diffusion MRI Techniques

49 patents: Sort by Forward Citations

1. 9447166 - Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors (2016-09-20),

2. 8591537 - Surgical appratus for cutting tissue (2013-11-26),

3. 8524228 - Netrin-1 compositions and methods of use thereof (2013-09-03),

4. 8461114 - Methods and compositions for modulating ErbB2 activity (2013-06-11),

5. 8435947 - Endothelial nitric oxide synthase antagonists and uses thereof for inhibiting oxygen toxicity (2013-05-07),

6. 8431392 - Shortened Alk1 regulatory fragment (2013-04-30),

7. 8309534 - Compositions comprising a GPR109 ligand for treating disorders of the digestive tract and/or cancer (2012-11-13),

8. 8287923 - Compositions and methods for treating immune disorders (2012-10-16),

9. 8236765 - Ganglioside epitopes for treating guillain-barre syndrome (2012-08-07),

10. 8216787 - Biomarker for successful aging without cognitive decline (2012-07-10),

11. 8211864 - Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors (2012-07-03),

12. 8198265 - Regulation of T cell-mediated immunity by tryptophan (2012-06-12),

13. 8169216 - System and method for synthesizing crossing ADC distributions via reassembly of multiple k-spaces (2012-05-01),

14. 8134363 - Test object for use with diffusion MRI and system and method of synthesizing complex diffusive geometries using novel gradient directions (2012-03-13),

15. 8098068 - Systems and methods for parametric mapping for correction of noise-based systematic bias of DTI metrics, using a DTI mapping phantom (2012-01-17),

The Medical College of Georgia Research Institute, Inc. is a leading research institution specializing in various fields of medical science. With a focus on cutting-edge technology and innovative research, our team of dedicated scientists and healthcare professionals strive to advance medical knowledge and improve patient care. Visit our website to learn more about our ongoing projects, collaborations, and contributions to the field of medical research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

49 Patents

#3 in Augusta, GA

#147 in Georgia

#6,914 in US

#13,866 in the World

Augusta, GA, United States of America

Medical College of Georgia Research Institute, Inc.

Forward Citations = 680

70 inventors:

David Munn (8 out of 12 patents)

Andrew L Mellor (8 out of 12 patents)

Nathan E Yanasak (4 out of 5 patents)

4. Tom C Hu (3 out of 3 patents)

5. Jeffrey Roberts Lee (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…